Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
60 Maglern, Arnoldstein, Kärnten, 9602, AT
David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support today’s drug products.
Released By Samsung Biologics
New joint venture will exclusively provide USP and EP-specific monograph testing for all frequently used gases in the drug and medical device development and manufacturing process.
By: Charlie Sternberg
Verve's programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strongly linked to cardiovascular disease.
Lubman has experience across small to large-cap private and public biopharmaceutical companies.
Ateganosine is currently being evaluated in a pivotal Phase 2 THIO-101 clinical trial in the treatment of non-small cell lung cancer.
By: Rachel Klemovitch
Practical solutions to purification and analytical challenges in PDC manufacturing, along with insights into synthesizing complex peptides, oligonucleotides, and conjugates.
Released By NAGASE & CO., LTD.
New treatment could transform care for patients with early gastric and gastroesophageal junction cancers.
Strengthens its presence in North America near its existing manufacturing facility.
Approval is based on GMMG-HD7 phase 3 study for those who are transplant-eligible, newly diagnosed with multiple myeloma.
Dr. Cristian Massacesi will oversee the company’s early-stage and late-stage product development across all therapeutic areas.
Aim to advance covalent medicines with the potential to address unmet medical needs and historically undruggable targets.
Enrollment is ongoing in a U.S. Phase 1/2a trial for VS-7375 in KRAS G12D advanced solid tumors
Gains exclusive rights for the development, manufacturing and commercialization of 3SBio’s SSGJ-707.
Will support its ongoing capital expenditure projects in Italy and the U.S.
Aims to provide clients with quicker access to compounds, potentially accelerating drug discovery timelines and decision-making processes.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
